AmCham Industry Series

Biotechnology: Health is the new Wealth

Longevity is every individual’s desire – but more importantly we want a quality of life - to fight disease, be physically fit and age well.

Health is big business and the potential for South Australia is enormous. Adelaide is home to one of the largest multi-disciplinary health precincts in the Southern Hemisphere featuring the South Australian Health and Medical Research Institute (SAHMRI) the Royal Adelaide Hospital , University of South Australia Cancer Research Institute and University of Adelaide Health and Medical Sciences building.

Research into important diseases such as malaria, AIDS, and tuberculosis; cardiovascular disease; many forms of cancer; plus the biology of aging with dementia, musculoskeletal disease and diabetes – means this will remain a top priority for Global Health Care. However, in addition to Research – South Australia is looking at was to commercialise this health research for the global market.

How is South Australia creating a competitive environment to generate new opportunities in the Health and Medical Industries? How will we grow our global reputation in this sector? Our panel of experts will explore the opportunities and supports for business and industry.

Welcom remarks delivery by Hon Stephen Wade MLC, Minister for Health and Wellbeing

Guest Speakers:

	Yvette van Eenennaam General Manager  Adelaide BioMed City   Yvette van Eenennaam commenced in the role as General Manager of Adelaide BioMed City just before its launch the end of 2018.  Adelaide BioMed City is a hub for health and life sciences in the heart of Adelaide combining significant infrastructure, including the new Royal Adelaide Hospital, the SA Health and Medical Research Institute (SAHMRI), and facilities for all three of the state’s universities. With an investment of $3.6 billion in medical, research and education infrastructure it welcomes around 2000 medical researchers, 10.000 staff and 18.000 daily visitors. And these numbers are increasing with the development of SAHMRI2 and the re-location of the Women’s and Children’s Hospital. The precinct encourages multi-institute and multi-disciplinary collaborations, including industry engagement, to drive social and economic impact. Before joining Adelaide BioMed City last year, Yvette has worked in leading roles in Europe for large multinationals, among others Deloitte, Nike Inc and ABN AMRO Bank, with a focus on strategy development, innovation and change management.
	Dr Terry Sweeney  Managing Director IBM Watson Health Originally from the UK and now based in Australia, Terry is responsible for an international multimillion-dollar business, developing innovative solutions for new and emerging markets at the intersection of AI, big data and healthcare. Recognised as a thought leader in healthcare innovation and technology, Terry’s industry insights are in regular demand from governments, healthcare organisations, public forums and media outlets, and is an advisor to a number of global organisations, including the G20. Most notably, Recently, Terry has been working at the forefront of the Chinese Government’s ‘Healthy China 2030’ national agenda, establishing a first of a kind partnership to bring innovative new technology to serve the healthcare needs of the largest population in the world. Terry has held a number of global senior strategic positions in both public and private sectors. Reporting to the Secretary of State for Health, Terry was the UK Government Special Advisor on the health and social care digital strategy, leading the transformation of front-line services through technology adoption. Terry has established and scaled two major start-ups; both being acquired by large global multinationals. He was a Founding Director of the social health technology start-up, Cúram Software. Based in Ireland, Cúram’s global presence and market leadership led to IBM acquiring the company in 2011. It remains part of the IBM Watson Health portfolio as a key platform for health and care management. Terry also founded a security software company based in the UK, focused on the gaming industry. A former professional athlete, Terry holds a Ph.D. in Economics from Cambridge University, a firstclass honours degree in Economics also from Cambridge University, and a Master of Science in Business Information Technology. Terry was honoured by HRH Queen Elizabeth II with a C.M.G. in recognition of his service overseas on behalf of the British Government.
	Professor Karen Reynolds Director Medical Device Research Institute (MDRI)  and Medical Device Partnering Program (MDPP) Dean (Research) , College of Science and Engineering, Flinders University Bridging the divide between research and industry, Karen is considered as one of Australia’s leading researchers in biomedical engineering and has been recognised for her outstanding contributions.  She became an Honorary Fellow of Engineers Australia in 2017, awarded Engineers Australia David Dewhurst award in 2016, South Australian Scientist of the Year 2012, elected Fellow of the Australian Academy of Technological Sciences (2011), and awarded Australian Professional Engineer of the Year (2010).   Karen holds a number of external roles including Member, Australian Medical Research Advisory Board and Director, Academy of Technological Sciences & Engineering Board.
Facilitator:	Dr Stephen Rodda, PhD MBA FAICD Chair  The Hospital Research Foundation A strategist with significant experience at Chief Executive and Director levels within technology development driven companies and the not-for-profit sector. Stephen is committed to the successful translation of research into outcomes that deliver social and economic benefit to our communities. He has actively driven the formation and financing of more than 15 companies, securing well in excess of AU$240 million in investment, grants and other funding. With a proven record for structuring and negotiating a variety of deals including strategic corporate partnerships, company acquisition, technology licences, joint venture, co-development and assignment transactions, Stephen has a truly international outlook with an established and demonstrated network of executive-level contacts across a variety of academic, government, commercial and investment groups in Asia, Europe, North America, New Zealand and Australia. Stephen was educated at The University of Adelaide gaining a first-class Honours degree, a PhD in Biochemistry and was awarded the University Medal. Subsequently he was awarded the prestigious CJ Martin and Arthritis Foundation Fellowships for post-doctoral training at Harvard University. Stephen holds a Masters of Business Administration, is a Fellow of the Australian Institute of Company Directors and has undertaken the Advanced Management Program (AMP) at the Harvard Business School. In his personal capacity, Stephen is Chair of The Hospital Research Foundation, and Chairman of Ferronova Pty Ltd, a venture capital backed medical device company advancing novel products for sentinel lymph node biopsies (SLNB) for diagnosis and staging of cancer.

Invitation transferable: feel free to forward this invitation to anyone within your organisation or networks who you think might be interested in this event.